The production of compliant pharmaceutical-quality cannabis-based medicines and ingredients requires significant experience in cultivation, R&D, GMP manufacturing, portfolio management, quality, and regulatory compliance.
Cannasouth’s people are our greatest assets, and we have assembled a highly experienced and vibrant team with over 200 years of combined GMP and pharmaceutical R&D experience.
The founders of the business have been involved in the industrial hemp industry since 1995 and gained one of the first licences to cultivate industrial hemp in New Zealand in 2002.
Cannasouth’s board members and directors have a broad range of business experience covering multiple industry sectors.
Tony Ho – Independent Non-Executive Chairman
Tony has a Bachelor of Commerce degree from The University of New South Wales, Sydney, is a member of The Institute of Chartered Accountants Australia and New Zealand, a Fellow of The Institute of Chartered Secretaries and Administrators, a Fellow of the Australian Institute of Company Directors, and a Fellow of the Governance Institute of Australia. Tony holds numerous non-executive directorships with a number of ASX and NZX listed companies. He was previously a director of Yates New Zealand Limited.
Mark Lucas – Managing Director and Chief Executive Officer
Mark is an experienced business manager who designs and implements operational business systems throughout Cannasouth. With strong data system DNA, Mark is a skilled manager who brings a wealth of business knowledge and experience to this role.
Mark’s business background spans 25 years. He is an entrepreneur by nature with a passion for business and has been involved in a number of businesses from initial conception through to mature, well-established companies. Mark’s key strengths include management, human resources/staff, project management, contract negotiation, sales and marketing, financial control, and business strategy.
Christine Pears – Independent Non-Executive Director
Christine is a Chartered Accountant with a Bachelor of Commerce from The University of Auckland, and is a member of the Institute of Directors.
She is currently the Independent Chair of Y North Inc and a Non-executive Director of McKay Limited, Franklin Veterinary Services, and NZX-listed Marlborough Wine Estates Group Limited.
Previously she held CEO roles within horticulture, laboratory services, and the wine sectors and Chief Financial Officer roles within an NZX-listed wine company, a successful property group, and several technology companies.
Hilary Webber – Independent Non-Executive Director
Hilary has a Bachelor of Social Sciences majoring in Psychology from The University of Waikato, a Master of Public Policy from Victoria University, is a member of the Institute of Directors, and is a former Registered Nurse.
Hilary’s expertise covers the areas of strategic and business growth, treasury and financial management, as well as innovation and research and development.
Her governance roles include being a former director of NZ Dairy Group (now Fonterra), AgResearch, Anchor Foods, Mighty River Power (now Mercury) and Westpac Advisory Board. She was the inaugural Chair and co-founder of the Dairy Women’s Network which has over 8,000 members.
Mark Scapens – Non-Executive Director
Mark has over 30 years of business experience covering horticulture, retail, wholesale, education and property sectors.
He has launched start-ups, bought businesses, and sold them. Mark’s experience includes 20 years in government-funded private education where he operated to high standards of compliance and service delivery.
Mark’s core strengths include an ability to envisage a big picture, long-range view, and an appetite for emerging industries. He loves creating something from nothing as well as breathing life back into businesses.
Greg Misson – Managing Director and Chief Innovation Officer
Greg is an inventor and entrepreneur with a passion for solving difficult problems.
His first enterprise, launched in 1984, developed innovations for the world’s rapidly expanding dairy processing industries. In 2003 he was founding director of New Zealand’s first large private dairy manufacturing company.
Greg has also been involved in airlines, architecture, business consulting and investment. He has a passion for taking organisations from concept to profit through smart thinking.
Colin Foster – Chief Financial Officer
Colin is a chartered accountant with a Bachelor of Management Studies and a Post-graduate Diploma in Treasury & Financial Management. He has 33 years of successful accounting and management experience, including 18 years as a Chief Financial Officer, during which time he was actively involved in strategy development and the establishment of a number of off-shore subsidiaries. Colin has a strong track record in financial modelling, treasury management, information systems management, and developing high-performing finance teams.
Tony Clark – Chief of Manufacturing
Tony has more than 20 years of engineering, manufacturing, and pharmaceutical industry experience, having worked with Pentair Valves & Controls Pacific Pty Ltd and Douglas Manufacturing Ltd.
He is a highly professional senior business leader where previous roles have included General Manager and Operations Manager. Tony has worked extensively in full GMP environments and is a member of NZPICS (Association for Operations and Supply Chain Professionals).
Pierre Booysen – Chief of Compliance
Pierre has extensive knowledge and experience in the medicinal cannabis industry and the New Zealand regulatory system, having worked as a Senior Advisor (GMP audit) with Medsafe and Team Leader with the Medicinal Cannabis Agency. He is a pharmacist by profession, with a background in various production, regulatory affairs and quality roles in the pharmaceutical industry. Pierre holds a Bachelor of Pharmacy and Master of Science in Pharmaceutical Chemistry.
David Macaskill – Chief Commercial Officer
David is a registered Trans-Tasman patent attorney, and barrister and solicitor of the High Court of New Zealand with a Master of Science (Chemistry) and Bachelor of Law.
He has 17 years’ experience in intellectual property strategy spanning a range of industries, including pharmaceuticals, animal healthcare, medical devices and software, artificial intelligence and machine learning, and agri-tech.
Before joining Eqalis as Strategy and Operations lead, David was a partner in New Zealand’s largest privately owned intellectual property specialist boutique. His passion is technology development and commercialisation.
Brendon Ogilvy – Chief Executive Officer – RestoreMe
Brendon is an experienced executive with a background in market research and online businesses.
He is the CEO of RestoreMe, having lead the business from concept to market launch.
Success for Brendon is about empowering team members to deliver smart, superior service to delight their customers.